Skip to main content
SpringerLink
Log in
Book cover

Stereotactic Body Radiation Therapy pp 1–8Cite as

Introduction

  • Chapter

  • 2296 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR) entails the precise and focused delivery of a small number of fractions of radiation in the ablative dose range to extracranial targets. Advances in technologies have facilitated safe and effective delivery of SBRT/SABR to various organ sites. The clinical experience with the use of SBRT/SABR to treat various extracranial organ sites has exponentially increased in the past 5–10 years in North America, Europe, and Asia. This chapter provides an introductory overview on various aspects of SBRT/SABR.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Blomgren H, Lax I, Naslund I, Svanstrom R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34(6):861–870

    Article  PubMed  CAS  Google Scholar 

  • Cardenes HR, Price TR, Perkins SM, Maluccio M, Kwo P, Breen TE, Henderson MA, Schefter TE, Tudor K, Deluca J, Johnstone PA (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 12(3):218–225

    Article  PubMed  CAS  Google Scholar 

  • Chang BK, Timmerman RD (2007) Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 30(6):637–644

    Article  PubMed  Google Scholar 

  • Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, Weinberg JS, Brown BW, Wang XS, Woo SY, Cleeland C, Maor MH, Rhines LD (2007) Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151–160

    Article  PubMed  Google Scholar 

  • Crabtree TD, Denlinger CE, Meyers BF, El Naqa I, Zoole J, Krupnick AS, Kreisel D, Patterson GA, Bradley JD (2010) Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 140(2):377–386. S0022-5223(10)00261-8[pii], doi:10.1016/j.jtcvs.2009.12.054

    Google Scholar 

  • Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, Schefter TE, Kavanagh BD, Larner JM (2010) Chest wall volume receiving >30 gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(3):796–801

    Article  PubMed  Google Scholar 

  • Forquer JA, Fakiris AJ, McGarry RC, Cheung MK, Watson C, Harkenrider M, Henderson MA, Lo SS (2009a) Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy. Expert Rev Anticancer Ther 9(10):1443–1453. doi:10.1586/era.09.117

    Article  Google Scholar 

  • Forquer JA, Fakiris AJ, Timmerman RD, Lo SS, Perkins SM, McGarry RC, Johnstone PA (2009b) Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol 93(3):408–413

    Article  Google Scholar 

  • Fuks Z, Kolesnick R (2005) Engaging the vascular component of the tumor response. Cancer Cell 8(2):89–91

    Article  PubMed  CAS  Google Scholar 

  • Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, Wloch J, Ye H, Kestin LL (2010) Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 28(6):928–935. JCO.2009.25.0928[pii], doi:10.1200/JCO.2009.25.0928

    Google Scholar 

  • Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR (1995) Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 36(2):311–319

    Article  PubMed  CAS  Google Scholar 

  • Hoppe BS, Laser B, Kowalski AV, Fontenla SC, Pena-Greenberg E, Yorke ED, Lovelock DM, Hunt MA, Rosenzweig KE (2008) Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who’s at risk? Int J Radiat Oncol Biol Phys 72(5):1283–1286

    Article  PubMed  Google Scholar 

  • Ishiyama H, Teh BS, Lo SS, Mathews T, Blanco A, Amato R, Ellis RJ, Mayr NA, Paulino AC, Xu B, Butler BE (2011) Stereotactic body radiation therapy for prostate cancer. Future Oncol 7(9):1077–1086. doi:10.2217/fon.11.86

    Article  PubMed  Google Scholar 

  • Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA (2004) Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58(4):1017–1021

    Article  PubMed  Google Scholar 

  • Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP (2005) Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 63(2):320–323

    Article  PubMed  Google Scholar 

  • Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA (2009a) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585–1591

    Article  Google Scholar 

  • Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, Beckett M, Sharma R, Chin R, Tu T, Weichselbaum RR, Fu YX (2009b) Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114(3):589–595

    Article  CAS  Google Scholar 

  • Lo SS, Cardenes HR, Teh BS, Fakiris AJ, Henderson MA, Papiez L, McGarry RC, Wang JZ, Li K, Mayr NA, Timmerman RD (2008) Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Rev Anticancer Ther 8(12):1939–1951

    Article  PubMed  Google Scholar 

  • Lo SS, Fakiris AJ, Teh BS, Cardenes HR, Henderson MA, Forquer JA, Papiez L, McGarry RC, Wang JZ, Li K, Mayr NA, Timmerman RD (2009) Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther 9(5):621–635

    Article  PubMed  Google Scholar 

  • Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD (2010a) Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 7(1):44–54

    Article  Google Scholar 

  • Lo SS, Teh BS, Mayr NA, Olencki TE, Wang JZ, Grecula JC, Lu JJ, Timmerman RD (2010b) Stereotactic body radiation therapy for oligometastases. Discov Med 10(52):247–254

    Google Scholar 

  • Mayr NA, Huang Z, Sohn JW, Lo SS, Teh BS, Lu JJ, Grecula JC, Kunos C (2011) Emerging application of stereotactic body radiation therapy for gynecologic malignancies. Expert Rev Anticancer Ther 11(7):1069–1075. doi:10.1586/era.11.81

    Article  PubMed  Google Scholar 

  • Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, Okunieff P (2008) A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 112(3):650–658

    Article  PubMed  Google Scholar 

  • Park C, Papiez L, Zhang S, Story M, Timmerman RD (2008) Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70(3):847–852

    Article  PubMed  Google Scholar 

  • Rose PS, Laufer I, Boland PJ, Hanover A, Bilsky MH, Yamada J, Lis E (2009) Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 27(30):5075–5079. JCO.2008.19.3508[pii], doi:10.1200/JCO.2008.19.3508

    Google Scholar 

  • Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE (2009a) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578

    Article  Google Scholar 

  • Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE (2009b) Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27(10):1579–1584

    Article  Google Scholar 

  • Sahgal A, Ma L, Gibbs I, Gerszten PC, Ryu S, Soltys S, Weinberg V, Wong S, Chang E, Fowler J, Larson DA (2010a) Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 77(2):548–553. S0360-3016(09)00772-X[pii], doi:10.1016/j.ijrobp.2009.05.023

    Google Scholar 

  • Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, Werner-Wasik M, Angelov L, Chang EL, Sohn MJ, Soltys SG, Letourneau D, Ryu S, Gerszten PC, Fowler J, Wong CS, Larson DA (2010b) Reirradiation HUMAN spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. S0360-3016(10)03067-1[pii], doi:10.1016/j.ijrobp.2010.08.021

  • Salama JK, Chmura SJ, Mehta N, Yenice KM, Stadler WM, Vokes EE, Haraf DJ, Hellman S, Weichselbaum RR (2008) An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res 14(16):5255–5259

    Article  PubMed  CAS  Google Scholar 

  • Schellenberg D, Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC (2008) Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 72(3):678–686

    Article  PubMed  CAS  Google Scholar 

  • Shirato H, Shimizu S, Shimizu T, Nishioka T, Miyasaka K (1999) Real-time tumour-tracking radiotherapy. Lancet 353(9161):1331–1332. S0140-6736(99)00700-X[pii], doi:10.1016/S0140-6736(99)00700-X

    Google Scholar 

  • Siddiqui F, Raben D, Lu JJ, Grecula JC, Lo SS, Huang Z, Mayr NA, Teh BS, Yao M (2011) Emerging applications of stereotactic body radiation therapy for head and neck cancer. Expert Rev Anticancer Ther 11(9):1429–1436. doi:10.1586/era.11.110

    Article  PubMed  Google Scholar 

  • Svedman C, Sandstrom P, Pisa P, Blomgren H, Lax I, Kalkner KM, Nilsson S, Wersall P (2006) A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 45(7):870–875

    Article  PubMed  Google Scholar 

  • Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24(30):4833–4839. 24/30/4833[pii], doi:10.1200/JCO.2006.07.5937

    Google Scholar 

  • Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11):1070–1076. 303/11/1070[pii], doi:10.1001/jama.2010.261

    Google Scholar 

  • Timmerman RD, Kavanagh BD (2005) Stereotactic body radiation therapy. Curr Probl Cancer 29(3):120–157

    Article  PubMed  Google Scholar 

  • Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25(8):947–952

    Article  PubMed  Google Scholar 

  • Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26(4):657–664

    Article  PubMed  Google Scholar 

  • Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, Ozeki Y, Aoki T, Watanabe M, Kusano S (1998) Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 82(6):1062–1070

    Article  PubMed  CAS  Google Scholar 

  • Wang JZ, Huang Z, Lo SS, Yuh WT, Mayr NA (2010) A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci Transl Med 2(39):39ra48. 2/39/39ra48[pii], doi:10.1126/scitranslmed.3000864

  • Wolbarst AB, Chin LM, Svensson GK (1982) Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys 8(10):1761–1769

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, 44106, USA

    Simon S. Lo

  2. Department of Radiation Oncology, The Methodist Hospital Cancer Center and Research Institute, Weill Cornell Medical College, Houston, TX, 77030, USA

    Bin S. Teh

  3. Department of Radiation Oncology, National University Cancer Institute of Singapore, National University of Singapore, Singapore, Singapore

    Jiade J. Lu

  4. Department of Radiation Oncology, University of Colorado Denver, Aurora, CO, 80045, USA

    Tracey E. Schefter

Authors
  1. Simon S. Lo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bin S. Teh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiade J. Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tracey E. Schefter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon S. Lo .

Editor information

Editors and Affiliations

  1. , Department of Radiation Oncology, Case Western Reserve University, Euclid Avenue 11100, Cleveland, 44106, Ohio, USA

    Simon S. Lo

  2. , Department of Radiation Oncology, Weil Cornell Medical College, Fannin, Ste#DB1-077 6565, Houston, 77030, Texas, USA

    Bin S. Teh

  3. Cancer Institute, Department of Radiation Oncology, National University Hospital, Lower Kent Ridge Road 5, Singapore, 119074, Singapore

    Jiade J. Lu

  4. , Department of Radiation Oncology, University of Colorado, Aurora, 80045, Colorado, USA

    Tracey E. Schefter

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lo, S.S., Teh, B.S., Lu, J.J., Schefter, T.E. (2011). Introduction. In: Lo, S., Teh, B., Lu, J., Schefter, T. (eds) Stereotactic Body Radiation Therapy. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_457

Download citation

  • DOI: https://doi.org/10.1007/174_2011_457

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-25604-2

  • Online ISBN: 978-3-642-25605-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation